CFM Pharma Holding has a management team with extensive experience in life science and the development of medicines.

  • Jos Fleskens

    BBA Hospital Management, CEO, fulfilled several European Management positions in life science (cardiovascular) at companies such as Norian and Baxter (Edwards Life science Division).

  • Lekhram-Changoer

    BSc. MSc. Chemist, President/COO, entrepreneur in life science, more than 24 years of experience at top management/Managing Director level.

  • Henk J. C. Meijerink

    MSc. CTO, biochemist, developed and patented various technologies, 20 years of experience in setting up life science companies.

  • Dr. Sjef de Kimpe

    PhD. Pharmacologist, Development consultant. Vice-president early drug development at BioMarin.

  • Bert Plekkenpol

    BSc. Chemist, Project Director, more than 40 years of experience in various life science positions at Solvay Pharmaceuticals in Europe and in the USA.

  • In addition, CFM Pharma Holding supported by multiple expert consultants with extensive experience in pharmaceutical development and by a strong Advisory Board of experts in their respective fields.


CFM Pharma has entered into partnerships with a number of private investors to raise the funding for the preclinical and Phase I trials conducted so far.

For the funding of the Phase II trials and to commercialize its products, CFM Pharma is open for partnerships with specialized Venture Capitalist, private investors and pharmaceutical companies.